Steven M Opal1. 1. Department of Medicine, Brown Medical School, Providence, RI, USA.
Abstract
OBJECTIVE: To define and introduce the PIRO model for categorizing sepsis in infants and children. DESIGN: A summary of the literature published during the 5 yrs since this concept has been formulated, along with a consensus opinion of experts in the field of sepsis and septic shock. RESULTS: The imprecision and intrinsic heterogeneity of the patient population defined as septic has prompted the introduction of a new sepsis classification system known as PIRO. PIRO stands for predisposition, infection, response, and organ dysfunction. It is hoped that by defining the septic process through a detailed analysis of each of its component parts, the development of sepsis will be better understood. This may contribute to improved therapeutic interventions for sepsis in the future. CONCLUSIONS: The PIRO model is a conceptual framework for understanding sepsis that has many favorable attributes. The PIRO model should be directly tested in both the research laboratory and in clinical trial designs to determine the practical value and clinical relevance of this new classification scheme for sepsis.
OBJECTIVE: To define and introduce the PIRO model for categorizing sepsis in infants and children. DESIGN: A summary of the literature published during the 5 yrs since this concept has been formulated, along with a consensus opinion of experts in the field of sepsis and septic shock. RESULTS: The imprecision and intrinsic heterogeneity of the patient population defined as septic has prompted the introduction of a new sepsis classification system known as PIRO. PIRO stands for predisposition, infection, response, and organ dysfunction. It is hoped that by defining the septic process through a detailed analysis of each of its component parts, the development of sepsis will be better understood. This may contribute to improved therapeutic interventions for sepsis in the future. CONCLUSIONS: The PIRO model is a conceptual framework for understanding sepsis that has many favorable attributes. The PIRO model should be directly tested in both the research laboratory and in clinical trial designs to determine the practical value and clinical relevance of this new classification scheme for sepsis.
Authors: Christopher W Seymour; Vincent X Liu; Theodore J Iwashyna; Frank M Brunkhorst; Thomas D Rea; André Scherag; Gordon Rubenfeld; Jeremy M Kahn; Manu Shankar-Hari; Mervyn Singer; Clifford S Deutschman; Gabriel J Escobar; Derek C Angus Journal: JAMA Date: 2016-02-23 Impact factor: 56.272
Authors: Derek S Wheeler; Howard E Jeffries; Jerry J Zimmerman; Hector R Wong; Joseph A Carcillo Journal: World J Pediatr Congenit Heart Surg Date: 2011-07-01
Authors: Sarah A Horst; Anna Linnér; Andreas Beineke; Sabine Lehne; Claudia Höltje; Alexander Hecht; Anna Norrby-Teglund; Eva Medina; Oliver Goldmann Journal: J Innate Immun Date: 2013-04-04 Impact factor: 7.349
Authors: Cristina Malzoni Ferreira Mangia; Niranjan Kissoon; Otavio Augusto Branchini; Maria Cristina Andrade; Benjamin Israel Kopelman; Joe Carcillo Journal: PLoS One Date: 2011-06-03 Impact factor: 3.240
Authors: Mark E Nunnally; Ricard Ferrer; Greg S Martin; Ignacio Martin-Loeches; Flavia R Machado; Daniel De Backer; Craig M Coopersmith; Clifford S Deutschman Journal: Intensive Care Med Exp Date: 2021-07-02
Authors: P Van de Voorde; B Emerson; B Gomez; J Willems; D Yildizdas; I Iglowstein; E Kerkhof; N Mullen; C R Pinto; T Detaille; N Qureshi; J Naud; J De Dooy; R Van Lancker; A Dupont; N Boelsma; M Mor; D Walker; M Sabbe; S Hachimi-Idrissi; L Da Dalt; H Waisman; D Biarent; I Maconochie; H Moll; J Benito Journal: Eur J Pediatr Date: 2013-01-26 Impact factor: 3.183